153 results
Page 5 of 8
8-K
0wdhm1745 nj
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-99.1
cqqv6d7oxrf iognavym
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-99.2
xmyfgfstcmz60
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-99.1
hw9kh38c2z2nnwb5le
11 Sep 20
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
7:00am
8-K
xb451utrip4nlvvltlk8
11 Sep 20
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
7:00am
DEFA14A
5xt 5ux9rp
11 Sep 20
Additional proxy soliciting materials
7:00am
DEF 14A
8ya1wxy2fpney bo
9 Sep 20
Definitive proxy
4:00pm
PRE 14A
zwvxxi
10 Aug 20
Preliminary proxy
12:00am
424B5
koc66qb kk1lr33xll
7 Jul 20
Prospectus supplement for primary offering
4:32pm
10-K
EX-10.3
hwqu64t6
29 Jun 20
Annual report
4:02pm
10-K
EX-10.2
lybk8 twgmuclsic
29 Jun 20
Annual report
4:02pm
10-K
i21yizqyanx3do m8
29 Jun 20
Annual report
4:02pm
S-3
h4jhiop 7vn4jms
29 Jun 20
Shelf registration
12:00am
8-K
EX-99.1
smtv8bolmo zyj2
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
6-K
EX-99.1
xxbr0az3ye1lnlu
13 Nov 19
Current report (foreign)
7:55am
6-K
EX-99.1
6w0lt xkleoohppsp11
28 Aug 19
Current report (foreign)
4:05pm
F-3
qsbleg3fuvej
7 Aug 19
Shelf registration (foreign)
12:00am
6-K
EX-99.1
obqhbnpj
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
POS AM
oq6d42exw
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm